top of page
duy-nguyen-9WwWGeHEbmQ-unsplash_edited.png

Our People

manu_bhaskaran_edited_edited.jpg

Manu Bhaskaran
Risk Chairman and Independent Director

Manu is a Partner of The Centennial Group, a strategic advisory firm. He is also a Member of the Competition Appeals Board, Singapore; Member of the Regional Advisory Board for Asia of the International Monetary Fund; Council Member, Singapore Institute of International Affairs (SIIA); and Vice-President, Economics Society of Singapore. He is a Director of CIMB Investment Bank (Malaysia) and Japfa Ltd (Singapore). Previous board positions include Silk Air, IFS Capital, Surbana Corporation and Temasek companies Green Dot Capital and EH Holdings. Manu holds a bachelor’s degree in Economics, Cambridge University, UK, Masters in Public Administration, Harvard University USA.

fatt kah foo_edited.jpg

Dr. Foo Fatt Kah
Managing Director

Dr Foo is a co-founder of Luminor Capital Pte Ltd and has over 30 years’ experience in investment banking, venture capital and fund management. He was previously Head of Asian Equities and Co-Head of the Investment Bank for SG Securities Asia and latterly venture partner for Aravis Ventures, a global venture capital group. He has been Managing Director of Luminor Capital since 2008. Dr. Foo is qualified in Medicine (M.B., B. Ch., B.A.O.) and Business Administration (MBA) from Queen's University, UK.

Kwan Chee Seng_edited.jpg

Kwan Chee Seng
Non-Excutive Director

Chee Seng is a co-founder of Luminor Capital Pte Ltd, and has over 30 years of experience as a businessman and investor. He has an established track record in investments, corporate restructuring, and M&A. Chee Seng has sat on the boards of numerous listed companies as a major shareholder. Presently, he is an Executive Director of SGX Mainboard-listed GRP Limited and also a Non-Executive Director of SGX listed Luminor Financial Holdings Ltd.

Yena Ho
Assistant Director,

Compliance and Administration

Yena has been with Luminor Capital since 2011, after various positions in the private corporate sector. Initially taking on the role as Office Manager, she has progressed to take on the additional role as Compliance Officer in 2013, taking responsibility for the company’s compliance, finance, HR and administrative functions. Yena graduated from the National University of Singapore with a Bachelor of Arts, a double major in Economics and General Mathematics.

Elissa Kwan
Assistant Director,

Operations

Elissa joined Luminor Capital in 2021, having previously been a Management Executive at GRP Ltd, an SGX-listed company. She oversees all operational aspects of the company’s policies and procedures including Risk Management and the running of the company’s operations. She also assists the management and board on business development matters. Elissa graduated with First Class (Honours) B.Sc., Business Management from King’s College London, UK. 

Alison Chong
Assistant Director,

Investment and Compliance

Alison first joined Luminor Capital in 2010 in the Marketing department as Client Liaison Officer. She progressed to become an Investment Associate, performing due diligence on investments, preparing investment reports and liaising with investors and investee companies.  Alison graduated from Shenzhen University, China, with a B.A. in English, and subsequently from the University of San Francisco, USA, with a Master’s in Language Education.

Wong Yoke Teng
Assistant Administrative Manager

Yoke Teng joined Luminor Capital in 2016 as an administrator following several years in administrative and management support, and customer service roles in the private corporate sector. She holds a tertiary education certificate in Business Information Technology.

Dr. Lawrence Chin
Consultant

Dr Chin is a consultant for Luminor Capital, having previously been the Executive Director for Investments, from 2011-2018. His prior experience includes 10 years as a senior investment professional at Bio*One Capital, a global healthcare fund under Singapore’s Economic Development Board (EDB), specialising in biotechnology, medical device, and healthcare services. He was also Bio*One Capital’s head of US operations between 2004 and 2007 based in San Francisco. Dr Chin graduated MBBS from the University of Western Australia and has an MBA.

bottom of page